HIV-1 Capsid as a Target for Antiviral Therapy

Journal of AIDS & Clinical Research
doi 10.4172/2155-6113.1000536
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Tyrosyl-Dna Phosphodiesterase 1 as a Target for Anticancer Therapy

2013English

Specific Inhibitors of HIV Capsid Assembly Binding to the CTerminal Domain of the Capsid Protein: Evaluation of 2Arylquinazolines as Potential Antiviral Compounds

English

Evidence for Positive Selection Driving the Evolution of HIV-1 Env Under Potent Antiviral Therapy

Virology
Virology
2001English

Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design

Frontiers in Immunology
AllergyImmunology
2017English

Orthogonal Genome-Wide Screenings in Bat Cells Identify MTHFD1 as a Target of Broad Antiviral Therapy

2020English

Reverse Transcriptase-Associated Ribonuclease H Activity as a Target for Antiviral Chemotherapy

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
1997English

High Frequency of Antiviral Drug Resistance and Non-B Subtypes in HIV-1 Patients Failing Antiviral Therapy in Cuba

Journal of Clinical Virology
VirologyInfectious Diseases
2012English

CPSF6 Defines a Conserved Capsid Interface That Modulates HIV-1 Replication

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2012English

Comparison of Biochemical Properties of HIV-1 and HIV-2 Capsid Proteins

Frontiers in Microbiology
Microbiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy